BB BIOTECH AG 13D and 13G filings for Black Diamond Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-21 1:01 pm Sale |
2025-03-19 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 2,733,547 4.800% |
-5,784,292 (-67.91%) |
Filing |
| 2025-02-14 2:36 pm Unchanged |
2024-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 8,517,839 15.100% |
0 (Unchanged) |
Filing |
| 2024-02-13 06:05 am Purchase |
2023-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 8,517,839 16.500% |
3,140,000 (+58.39%) |
Filing |
| 2023-02-14 4:14 pm Purchase |
2022-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 5,377,839 14.800% |
1,389,437 (+34.84%) |
Filing |
| 2022-04-14 12:01 pm Purchase |
2022-04-11 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 3,988,402 11.000% |
548,402 (+15.94%) |
Filing |
| 2022-02-11 4:57 pm Purchase |
2021-12-31 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 3,440,000 9.500% |
1,540,000 (+81.05%) |
Filing |
| 2021-02-11 4:58 pm Purchase |
2021-02-03 | 13G | Black Diamond Therapeutics, Inc. BDTX |
BB BIOTECH AG | 1,900,000 5.300% |
1,900,000 (New Position) |
Filing |